Ceremorphic Life Sciences CEO Delivers Keynote at AI Driven Drug Discovery Summit; Demonstrates New Bio-supercomputing Platform that Can Speed Every Phase of Drug Discovery and Development
New BioCompDiscoverX® system leverages analog, quantum, and AI technology to drive new levels of efficiency in the entire drug development pipeline; The ability to significantly lower development costs, shorten time-to-market and improve efficacy will deliver billions of dollars in savings to the pharmaceutical Industry; CEO Venkat Mattela demonstrated the BioCompDiscoverX system features for the first time on stage during show keynote; unveiling new technology details around the platform
